PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-10.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.18B
AUM Growth
+$3.18B
(-36%)
Cap. Flow
-$557M
Cap. Flow
% of AUM
-17.5%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
144
New
7
Increased
15
Reduced
49
Closed
31
Top Buys
| 1 |
Amylyx Pharmaceuticals
AMLX
|
$39.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.6M |
| 3 |
Lyra Therapeutics
LYRA
|
$33.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.6M |
| 5 |
Eli Lilly
LLY
|
$32.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$143M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$52.5M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$34.5M |
| 4 |
Penumbra
PEN
|
$31.9M |
| 5 |
Travere Therapeutics
TVTX
|
$30.9M |
Sector Composition
| 1 | Healthcare | 84.05% |
| 2 | Consumer Discretionary | 0.04% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATNX
76
DELISTED
Athenex, Inc. Common Stock
ATNX
| $5.54M | 0.17% |
13,532,467
| – | – |
|
77
Aclaris Therapeutics
ACRS
$223M
| $4.76M | 0.15% |
341,239
-42,000
| -11% | -$586K |
|
|
NBTX
78
Nanobiotix
NBTX
$415M
| $4.03M | 0.13% |
1,059,800
| – | – |
|
|
QTNT
79
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $3.89M | 0.12% |
16,200,818
| – | – |
|
80
Astria Therapeutics
ATXS
$394M
| $3.84M | 0.12% |
1,281,197
| – | – |
|
81
Pyxis Oncology
PYXS
$91.2M
| $3.64M | 0.11% |
1,528,812
| – | – |
|
82
MacroGenics
MGNX
$121M
| $3.62M | 0.11% |
1,227,202
-332,587
| -21% | -$981K |
|
83
Tyra Biosciences
TYRA
$657M
| $3.54M | 0.11% |
494,403
| – | – |
|
84
Clover Health Investments
CLOV
$1.36B
| $3.21M | 0.1% |
1,500,000
| – | – |
|
85
Y-mAbs Therapeutics
YMAB
$390M
| $3.21M | 0.1% |
+212,018
| New | +$3.21M |
|
|
SNCE
86
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $3.02M | 0.09% |
1,500,000
| – | – |
|
87
Absci
ABSI
$356M
| $2.97M | 0.09% |
894,346
-296,606
| -25% | -$985K |
|
88
enVVeno Medical
NVNO
$15M
| $2.95M | 0.09% |
781,615
| – | – |
|
|
FUSN
89
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.62M | 0.08% |
1,052,445
-174,572
| -14% | -$435K |
|
90
Hyperfine
HYPR
$88M
| $2.53M | 0.08% |
1,134,388
-365,612
| -24% | -$815K |
|
91
Acumen Pharmaceuticals
ABOS
$84.2M
| $2.39M | 0.07% |
508,532
-88,410
| -15% | -$416K |
|
92
Relmada Therapeutics
RLMD
$48.8M
| $2.3M | 0.07% |
121,350
-30,000
| -20% | -$570K |
|
93
DarioHealth
DRIO
$22.6M
| $2.01M | 0.06% |
327,869
| – | – |
|
94
Fulcrum Therapeutics
FULC
$353M
| $1.44M | 0.05% |
294,118
| – | – |
|
|
PEAR
95
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
| $1.39M | 0.04% |
900,548
-25,684
| -3% | -$39.5K |
|
96
Ferrari
RACE
$88.2B
| $1.14M | 0.04% |
6,200
| – | – |
|
|
SONX
97
DELISTED
Sonendo, Inc.
SONX
| $1.12M | 0.03% |
648,505
-20,000
| -3% | -$34.4K |
|
|
ZY
98
DELISTED
Zymergen Inc. Common Stock
ZY
| $1.09M | 0.03% |
883,332
| – | – |
|
99
Protara Therapeutics
TARA
$125M
| $850K | 0.03% |
290,051
-93,475
| -24% | -$274K |
|
|
AGRX
100
DELISTED
Agile Therapeutics, Inc
AGRX
| $620K | 0.02% |
532,361
-20,762,124
| -98% | – |
|